RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..2 of 2 - per page
Order by
Bestnem
Bestnem(Imipenem and cilastatin ) More
CollaRx® & LiquiColl® Technologies
Collagen-based biodegradable matrices for localized drug delivery More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
The National Institute of Allergy and Infectious Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Infectious Diseases Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015
May 2011 - 150 pages - $3,995
Development of New Antibiotics Hits a Road Block
Sep 2011 - 6 pages - $500
Animal Health Products Antibacterials Markets
May 2008 - 70 pages - $1,999
Neurodegenerative Diseases: World Drug Market 2011-2026
Nov 2010 - 18 pages - $2,350
The Global Antibacterials Market R&D Pipelines, Market Analysis and Competitive Landscape
Aug 2007 - 126 pages - $2,499
Infectious Disease Research Institute – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 28 pages - $500
Stakeholder Opinions: Biologics in Infectious Diseases Well defined target populations are key to commercial success
Mar 2008 - 123 pages - $3,800
Autoimmune Diseases Therapy Area Pipeline Report
Nov 2010 - 399 pages - $1,495
More Related Market Research Reports >>>

Your selection

Therapeutic target
Infectious diseases del
Treatments del
Antibiotics del
Development phase
Phase III del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us